Financhill
Back

Aldeyra Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
30

ALDX
Aldeyra Therapeutics

Last Price:
4.21
Seasonality Move:
5.49%
Sell
33

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
30
Aldeyra Therapeutics (ALDX) is a Sell

Is Aldeyra Therapeutics a Buy, Sell or Hold?

  • The current Aldeyra Therapeutics [ALDX] share price is $4.21. The Score for ALDX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ALDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALDX Stock Price Chart

What is Aldeyra Therapeutics's stock price today?

  • The Aldeyra Therapeutics share price today is $4.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALDX is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

ALDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 28.96 Sell
Chaikin Money Flow: -517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.87 - 5.69) Sell
Bollinger Bands (100): (3.98 - 5.8) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 53.49 Buy
Chaikin Money Flow: -8154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.74) Buy
Bollinger Bands (100): (0.27 - 1.57) Sell

ALDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.92 Sell
20-day SMA: 5.22 Sell
50-day SMA: 5.46 Sell
200-day SMA: 4.29 Sell
8-day EMA: 4.74 Sell
20-day EMA: 5.08 Sell
50-day EMA: 5.2 Sell
200-day EMA: 4.75 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.68 Buy
50-day SMA: 0.64 Buy
200-day SMA: 2.44 Sell
8-day EMA: 0.72 Sell
20-day EMA: 0.7 Buy
50-day EMA: 0.74 Sell
200-day EMA: 5.82 Sell

Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.14 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Aldeyra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):